Beyond promoting metastasis, the METTL1/WDR4 complex in nasopharyngeal carcinoma contributes to resistance against cisplatin and docetaxel through the aforementioned mechanisms [246]. Here, WDR4 is linked to nasopharyngeal carcinoma.